Lasry Marc’s Exela Technologies, Inc. 6.00% Series B Cumulative Convertible Perpetual Preferred Stock XELAP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-77,498
Closed -$16.3K 10
2025
Q2
$16.3K Hold
77,498
0.09% 8
2025
Q1
$17.1K Hold
77,498
0.08% 10
2024
Q4
$27.9K Hold
77,498
0.12% 11
2024
Q3
$124K Hold
77,498
0.23% 10
2024
Q2
$132K Hold
77,498
0.13% 11
2024
Q1
$157K Hold
77,498
0.13% 11
2023
Q4
$130K Hold
77,498
0.19% 10
2023
Q3
$226K Hold
77,498
0.22% 11
2023
Q2
$318K Hold
77,498
0.41% 11
2023
Q1
$231K Hold
77,498
0.44% 10
2022
Q4
$226K Hold
77,498
0.35% 11
2022
Q3
$376K Hold
77,498
0.72% 10
2022
Q2
$542K Buy
+77,498
New +$527K 0.82% 11

Other funds holding XELAP

Lasry Marc's XELAP Position: Q3 2025 in Review

Lasry Marc sold out of Exela Technologies, Inc. 6.00% Series B Cumulative Convertible Perpetual Preferred Stock (XELAP) in Q3 2025, closing a stake of 77,498 shares — an estimated $16.3K sold.

Lasry Marc first reported a position in XELAP in Q2 2022 and held it in 13 quarters. The position peaked at $542K in Q2 2022. 5 funds tracked by Wall St. Rank hold XELAP as of Q3 2025.

  • Lasry Marc reported no remaining Exela Technologies, Inc. 6.00% Series B Cumulative Convertible Perpetual Preferred Stock position as of Q3 2025 after selling out during the quarter.
  • Lasry Marc sold 77,498 Exela Technologies, Inc. 6.00% Series B Cumulative Convertible Perpetual Preferred Stock shares in Q3 2025, an estimated $16.3K.
  • Lasry Marc first reported a position in Exela Technologies, Inc. 6.00% Series B Cumulative Convertible Perpetual Preferred Stock in Q2 2022 and held it in 13 quarters.
  • Lasry Marc's Exela Technologies, Inc. 6.00% Series B Cumulative Convertible Perpetual Preferred Stock position peaked at $542K in Q2 2022.
  • 5 funds tracked by Wall St. Rank held Exela Technologies, Inc. 6.00% Series B Cumulative Convertible Perpetual Preferred Stock as of Q3 2025.

Based on Lasry Marc's 13F filing for Q3 2025, filed 14 Nov 2025.